BiotechTube

Eszopiclone 1 mg- Elderly + Eszopiclone 2 mg- Elderly + Eszopiclone 3 mg- Non-elderly + Eszopiclone 2 mg- Non-elderly

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Insomnia

Conditions

Insomnia

Trial Timeline

Oct 1, 2008 → May 1, 2010

NCT ID
NCT00770692

About Eszopiclone 1 mg- Elderly + Eszopiclone 2 mg- Elderly + Eszopiclone 3 mg- Non-elderly + Eszopiclone 2 mg- Non-elderly

Eszopiclone 1 mg- Elderly + Eszopiclone 2 mg- Elderly + Eszopiclone 3 mg- Non-elderly + Eszopiclone 2 mg- Non-elderly is a phase 3 stage product being developed by Eisai for Insomnia. The current trial status is completed. This product is registered under clinical trial identifier NCT00770692. Target conditions include Insomnia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00770692Phase 3Completed

Competing Products

20 competing products in Insomnia

See all competitors
ProductCompanyStageHype Score
ACT-541468 5 mg + ACT-541468 10 mg + ACT-541468 25 mg + Zolpidem + Placebo 1 + Placebo 2IdorsiaPhase 2
47
Zolpidem (Myslee®) + placeboAstellas PharmaApproved
85
zolpidemAstellas PharmaApproved
85
Mirtazapine TabletsSun PharmaceuticalApproved
85
Lemborexant (LEM) 5 mg (Z-Drug-mono cohort) + Lemborexant (LEM) 5 mg (SUV-mono cohort) + Lemborexant (LEM) 5 mg (SUV-combination cohort) + Lemborexant (LEM) 5 mg (RMT-combination cohort)EisaiApproved
85
E2006 1.0 mg + E2006 2.5 mg + E2006 5.0 mg + E2006 10.0 mg + E2006 25.0 mg + E2006 50.0 mg + E2006 100 mg + E2006 200 mg + Zolpidem 10 mg + E2006 Matched Placebo or Zolpidem Matched Placebo + E2006 Matched PlaceboEisaiPhase 1
33
Lemborexant 5 mg + Lemborexant 10 mg + Lemborexant-matched placebo. + Flurazepam 30 mgEisaiPhase 1
33
E2006EisaiPhase 1
33
Lemborexant + Lemborexant + Lemborexant-matched placebo + Zolpidem tartrate + Zolpidem-matched placeboEisaiPhase 3
77
LEM 5 mg + LEM 10 mgEisaiPhase 3
77
EszopicloneEisaiPre-clinical
23
Eszopiclone 1 mg + Eszopiclone 2 mg + Eszopiclone 3 mg + Placebo + Zolpidem Tartrate 10 mgEisaiPhase 2/3
65
lemborexant + PlaceboEisaiPhase 3
77
E2006 + PlaceboEisaiPhase 2
52
Zolpidem tablets + Suvorexant tablets, over-encapsulated + Lemborexant tablets + Placebo lemborexant + Placebo zolpidem + Placebo suvorexantEisaiPhase 1
33
EszopicloneEisaiPre-clinical
23
Eszopiclone 3 mg + Eszopiclone 1 mgEisaiPhase 1
33
LY2624803Eli LillyPhase 1
33
LY2624803 - Capsules + Zolpidem - Tablets + Placebo - Capsules + Placebo - TabletsEli LillyPhase 1
33
LY2624803Eli LillyPhase 1
33

Other Products from Eisai

MecobalaminApproved
85
MonteplaseApproved
85
E2020 + PlaceboApproved
85
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVApproved
85
DonepezilApproved
85